Anzeige
Mehr »
Mittwoch, 20.08.2025 - Börsentäglich über 12.000 News
US-Start angekündigt: Bisher +175% Kursgewinn in 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
487 Leser
Artikel bewerten:
(2)

Avalere Health Appoints New President of Medical To Lead a Tech-Enabled Future of Medical Affairs

LONDON, Feb. 6, 2024 /PRNewswire/ -- Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical. Baoutis will lead a team of 350+ scientific communicators into a future of medical communications fueled by an alchemy of science, creativity and technology.

Avalere Health Logo.

Avalere Health has a deep heritage in this field, forming more than 20 years ago as a medical communications agency. Since then, it has evolved into a global commercialization partner, diversifying its offering to deliver from advisory to implementation across the entire product lifecycle.

The appointment of Baoutis is the latest of several high-profile executive leadership announcements made following Avalere Health's rebrand on October 18, 2023, each reflecting Avalere Health's evolution as a connected organization. The rebrand saw the company bring together 1,500+ team members across 19 locations in North America, Europe and Asia, uniting them under a single vision, organization and brand.

An established authority in healthcare communications, Baoutis is experienced in supporting large pharmaceutical clients and emerging biotech through her work at Omnicom, McCann Health, Real Chemistry and the Healthcare Communications Association. She is an expert in scientific engagement and has worked across a range of functions, including leadership roles in marketing and advertising. Her interdisciplinary approach and background make her well-positioned to collaborate across the business and develop advanced solutions to clients' medical communications challenges.

"While modular content, personalized messaging, omnichannel and content value metrics were traditionally the realm of marketing, Medical teams are beginning to see the benefits of these approaches for building deeply engaging experiences for healthcare professionals," said Amar Urhekar, Chief Operating Officer at Avalere Health. "Capitalizing on her cross-functional knowledge, Effie will ensure our experts infuse scientific information with the creativity and cutting-edge tools and platforms needed to support our clients in the technology-enabled future of medical communications."

Under Baoutis's leadership, the Medical team will support clients in remaining at the forefront of digital advancement, strategically leveraging the right tools, platforms and data to build cohesive learning experiences for customers. Her priorities include investing in new technology ecosystems to advance Avalere Health's heritage in experience design and delivery and bringing together the company's proprietary virtual congress platforms and publication planning tools. She will also work closely with Avalere Health's in-house technologists and analysts to explore the multidimensional application of artificial intelligence in medical communications.

"I'm thrilled to join as the President of Medical at Avalere Health during a paradigm shift in medical communications," said Baoutis. "The reputation of the team is unrivaled. We have the right combination of expertise to be a guiding light for our clients, helping them leverage the data, technologies and strategies to best meet their business goals and the needs of the stakeholders they serve."

About Avalere Health

Established in 2001, Avalere Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Its 1,500+ experts combine their knowledge and expertise across its core disciplines - Consulting; Medical; Policy, Access, Value, and Evidence; Marketing; and Digital Experience Technology - to create the connections that make better health happen.

Avalere Health partners with its clients to navigate the complex and rapidly changing healthcare ecosystem. Together, its experts help clients connect patients with life-changing therapies, realizing the potential of strategies and solutions to accelerate innovation that improves lives. Visit www.avalerehealth.com and follow Avalere Health on LinkedIn and Instagram.

Contact information

Natasha Cowan
natasha.cowan@avalerehealth.com

Adi Nat
adityavir.nat@avalerehealth.com

 Effie Baoutis, New President of Medical at Avalere Health.

Logo - https://mma.prnewswire.com/media/2334459/Avalere_Health_Logo_Logo.jpg

Photo - https://mma.prnewswire.com/media/2334460/Effie_Baoutis.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/avalere-health-appoints-new-president-of-medical-to-lead-a-tech-enabled-future-of-medical-affairs-302054600.html

© 2024 PR Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.